The World Antiviral Congress is part of the award-winning series of vaccine conferences
NEW BENEFITS:
- Larger attendance of experts in infectious disease and cancer immunotherapy
- A more holistic event that looks at how disease (including COVID-19) is managed preventatively and therapeutically
- See how vaccines, antivirals and antibodies all play a part in managing and preventing disease
- More networking and partnering opportunities with extended breaks and evening receptions
Covering All the Important Topics
"What a fantastic program in a very busy time, I deeply enjoyed the discussion and composition of speakers "
- Co-founder & Chair, Vienna Vaccine Safety Initiative
- Co-founder & Chair, Vienna Vaccine Safety Initiative
"The line-up was quite impressive..it was definitely worth it to travel half around the world"
- CSO, G.ST Antivirals
- CSO, G.ST Antivirals
"Congratulations on a very successful meeting…I found it to be extremely productive and worthwhile"
- Professor of Medicine-Infectious Diseases, Stanford University School of Medicine (USA)
- Professor of Medicine-Infectious Diseases, Stanford University School of Medicine (USA)
2022 World Leading Speakers
Dr Aeron Hurt
Principal Global Medical Science Director
Roche
Roche
Sara Woodson
Program Officer
NIH/NIAID
NIH/NIAID
Chief, Therapeutics Branch in Influenza and Emerging Diseases Division
BARDA
BARDA
Dr Howard Gendelman
Co-founder
Exavir Therapeutics
Exavir Therapeutics
Dr Kathie Seley-Radtke
Prof, Chemistry and Biochemistry
University of Maryland Baltimore County
University of Maryland Baltimore County
Dr Jay Grobler
Associate VP Infectious Disease and Vaccines
Merck And Company
Merck And Company
Director, Center for Aids Research
University of California San Diego
University of California San Diego
Dr Amy Jenkins
Program Manager
D.A.R.P.A.
D.A.R.P.A.
Dr Rob Jordan
Senior Program Officer
Bill & Melinda Gates Foundation
Bill & Melinda Gates Foundation
Col Mara Kreishman-Deitrick
Deputy Commander
United States Army Medical Material Development Activity
United States Army Medical Material Development Activity
Dr Jeffrey Glenn
Prof, Medicine and Microbiology & Immunology
Stanford University
Stanford University
Dr Takeki Uehara
DVM, PhD, Corporate Officer, Senior Vice President, Drug Development and Regulatory Science Division
Shionogi
Shionogi
Stay Up-to-Date
Join our mailing list to receive exclusive content and offers.
By submitting, you agree to receive email communications from Terrapinn, including upcoming promotions and discounted tickets and news.
For conference programme and speaking opportunities:
Lauren Sheppard
lauren.sheppard@terrapinn.com
For sponsorship and exhibition opportunities:
Thomas Hall
thomas.hall@terrapinn.com
Created by
Terrapinn is proud to be a member of isla.
Working together to build sustainable events